# Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)

> **NCT06748612** · PHASE4 · NOT_YET_RECRUITING · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 1190 (estimated)

## Conditions studied

- Polio

## Interventions

- **BIOLOGICAL:** Pentavalent vaccine
- **BIOLOGICAL:** Hexavalent vaccine
- **BIOLOGICAL:** Inactivated poliovirus vaccine (IPV)
- **BIOLOGICAL:** Bivalent oral polio vaccine (bOPV)
- **BIOLOGICAL:** Fractional IPV( fIPV)

## Key facts

- **NCT ID:** NCT06748612
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-28
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 1190 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06748612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06748612, "Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06748612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*